Generic loteprednol etabonate approval tops OSN’s news of the week

Here are some top stories on Healio.com/OSN in the past week:
 
FDA approves generic loteprednol etabonate from Akorn
The FDA has approved an abbreviated new drug application for Akorn’s loteprednol etabonate ophthalmic suspension 0.5%. Read more.
 
Ophthalmologists push for better access to care in annual Capitol Hill visit
In an effort to lobby for better access to care, discuss important issues with lawmakers and increase education, more than 400 ophthalmologists traveled to Washington recently for the American Academy of Ophthalmology’s annual Capitol Hill visit. Read